XEOMIN® is a prescription medicine, uniquely purified, used to temporarily reduce the appearance of moderate to severe frown lines that form between the eyebrows, around the outer area of eyes, and across the forehead in adults. Xeomin® works by blocking neural signals at the neuromuscular junction to prevent the targeted muscles from contracting. XEOMIN® is manufactured by Merz Pharmaceuticals and was approved by the FDA to ease the appearance of frown lines in 2010. Xeomin® contains botulinum toxin type A, which is a uniquely purified protein from the bacterium Clostridium botulinum. Due to its different form of botulinum toxin, it can be administered without any additive proteins.
You may see smoothing occurring as early as 3-4 days after injection treatment. Maximum effects are noticed between 2-4 weeks, lasting up to 3 months.